Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.628
-0.006 (-0.98%)
At close: Sep 11, 2024, 4:00 PM
0.630
+0.002 (0.32%)
After-hours: Sep 11, 2024, 4:44 PM EDT
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 100 employees as of December 31, 2023. The number of employees increased by 6 or 6.38% compared to the previous year.
Employees
100
Change (1Y)
6
Growth (1Y)
6.38%
Revenue / Employee
$111,660
Profits / Employee
-$661,660
Market Cap
24.03M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 100 | 6 | 6.38% |
Dec 31, 2022 | 94 | 3 | 3.30% |
Dec 31, 2021 | 91 | 26 | 40.00% |
Dec 31, 2020 | 65 | - | - |
Related Stocks
Company Name | Employees |
---|---|
DarioHealth | 294 |
Neuronetics | 203 |
Spectral AI | 78 |
Biora Therapeutics | 58 |
Pieris Pharmaceuticals | 50 |
Femasys | 34 |
Cognition Therapeutics | 28 |
Unity Biotechnology | 19 |
BOLT News
- 5 days ago - Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm - Accesswire
- 7 days ago - Bolt Biotherapeutics Announces Changes to its Board of Directors - GlobeNewsWire
- 7 days ago - Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm - Accesswire
- 9 days ago - BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 9 days ago - Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions - Accesswire
- 11 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - PRNewsWire
- 11 days ago - Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm - Accesswire
- 12 days ago - The Schall Law Firm Is Looking For Investors With Losses In Bolt Biotherapeutics Inc To Participate In A Securities Fraud Case - Accesswire